Inactive Instrument

Company Vical Incorporated Nasdaq

Equities

US9256022032

Biotechnology & Medical Research

Business Summary

Fresh Tracks Therapeutics, Inc. is not engaged in any business activities. The Company is in the process of dissolution.

Sales per Business

USD in Million2022Weight2023Weight Delta
Prescription Therapeutics
100.0 %
7 100.0 % 8 100.0 % +15.31%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
100.0 %
7 100.0 % 8 100.0 % +15.31%

Managers

Managers TitleAgeSince
Chief Executive Officer 72 20-11-30
Chief Tech/Sci/R&D Officer - 15-12-31
Comptroller/Controller/Auditor - 20-06-30
Corporate Officer/Principal - -
Human Resources Officer - -

Members of the board

Members of the board TitleAgeSince
Chief Executive Officer 72 20-11-30

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 5,973,306 5,877,545 ( 98.40 %) 0 98.40 %

Shareholders

NameEquities%Valuation
Exploration Capital LLC
18.55 %
1,107,807 18.55 % 1 M $
Telemetry Investments LLC
1.088 %
65,000 1.088 % 58 825 $
21,759 0.3643 % 19 692 $
16,371 0.2741 % 14 816 $
6,951 0.1164 % 6 291 $
ANGES, INC.
0.1094 %
6,535 0.1094 % 5 914 $
3,042 0.0509 % 2 753 $
Ronald Blue Trust, Inc.
0.0153 %
916 0.0153 % 829 $
Merrill Lynch Investment Managers, Inc.
0.001607 %
96 0.001607 % 87 $
Nordea Investment Management AB
0.000084 %
5 0.000084 % 5 $

Company contact information

Fresh Tracks Therapeutics, Inc.

5777 Central Avenue Suite 102

80301, Boulder

+

http://www.frtx.com
address Vical Incorporated
  1. Stock Market
  2. Equities
  3. FRTX Stock
  4. Stock
  5. Company Vical Incorporated